Novonesis (Novozymes A/S)
Trading by management and close relations of management
Trading by management and close relations of management
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novozymes A/S, part of Novonesis Group reports the following transactions under ISIN DK0060336014, Novonesis (Novozymes) B shares under the symbol NSIS B. The released shares relate to the 2022 legacy Chr. Hansen restricted stock units (RSU) program.
Please see the full announcement in pdf.
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
EBC Financial Group10.6.2025 04:23:08 CEST | Press release
EBC Financial Group and Brokeree Solutions Forge Strategic Knowledge Partnership to Empower Global Trading Community
Arcera Life Sciences10.6.2025 01:00:00 CEST | Press release
AriBio and Arcera Sign Exclusive Licensing and Supply Agreements for Investigational Drug for Alzheimer’s Disease
Leading Edge Materials Corp.9.6.2025 23:30:00 CEST | Press release
Leading Edge Materials Announces Change of Swedish Certified Adviser to SVENSK KAPITALMARKADSGRANSKNING ("SKMG")
Strategic Partners A/S9.6.2025 20:03:32 CEST | Pressemeddelelse
Aktietilbagekøb 2-6 juni 2025
Meriaura Group Oyj9.6.2025 20:00:00 CEST | Press release
Meriaura Group Plc: The merger of Meriaura Group Plc and Summa Defence Oy has been completed, sale of Meriaura Group Oy shares, directed acquisition and cancellation of own shares, change of company name and CEO
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom